IRIS
CAPRANZANO, PIERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.511
AS - Asia 2.586
EU - Europa 2.509
AF - Africa 360
SA - Sud America 357
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.329
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.269
SG - Singapore 1.409
CN - Cina 890
IE - Irlanda 862
UA - Ucraina 589
IT - Italia 436
BR - Brasile 335
CI - Costa d'Avorio 291
CA - Canada 231
RU - Federazione Russa 195
VN - Vietnam 133
SE - Svezia 122
FR - Francia 61
DE - Germania 58
GB - Regno Unito 55
SN - Senegal 42
KR - Corea 38
IN - India 28
UZ - Uzbekistan 22
NL - Olanda 20
BE - Belgio 19
CH - Svizzera 18
AT - Austria 17
FI - Finlandia 15
GR - Grecia 12
BD - Bangladesh 10
PL - Polonia 10
AR - Argentina 9
HK - Hong Kong 9
IQ - Iraq 9
ZA - Sudafrica 8
MA - Marocco 7
MX - Messico 7
TR - Turchia 7
ES - Italia 6
EU - Europa 5
JP - Giappone 5
PK - Pakistan 5
EC - Ecuador 4
KE - Kenya 4
NG - Nigeria 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IR - Iran 2
LB - Libano 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
DZ - Algeria 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
MT - Malta 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.329
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.123
Dublin 862
Singapore 812
Jacksonville 807
Chandler 684
Houston 497
Boardman 402
Abidjan 291
Nanjing 246
Chicago 231
Andover 215
Lawrence 214
Cambridge 213
Ashburn 184
Toronto 171
Des Moines 143
Catania 139
Dong Ket 125
Civitanova Marche 105
Nanchang 83
Wilmington 83
San Mateo 76
Hebei 64
Hefei 61
Shenyang 53
Beijing 51
Ottawa 48
Jiaxing 47
Saint Petersburg 45
Dakar 42
Los Angeles 41
Tianjin 39
Changsha 38
Seoul 38
The Dalles 37
Bremen 31
Council Bluffs 31
Washington 30
São Paulo 25
Moscow 24
Seattle 21
Norwalk 20
Brussels 19
Pune 18
Kunming 17
Ningbo 17
Falls Church 16
Hangzhou 16
Helsinki 14
Jinan 14
Milan 14
Rio de Janeiro 14
Belo Horizonte 13
Columbus 13
Guangzhou 12
Brooklyn 11
Den Haag 11
Phoenix 10
Zhengzhou 9
Hanoi 8
Hong Kong 8
Liberty Lake 8
Ann Arbor 7
Edinburgh 7
Palermo 7
San Francisco 7
Amsterdam 6
London 6
Munich 6
New York 6
Stockholm 6
Baghdad 5
Boston 5
Canicattini Bagni 5
Curitiba 5
Manduria 5
Padova 5
Porto Alegre 5
Recife 5
Shanghai 5
Taizhou 5
Tokyo 5
Abuja 4
Anápolis 4
Assago 4
Brasília 4
Casarano 4
Charlotte 4
Dallas 4
Johannesburg 4
Ludwigshafen 4
Mascalucia 4
Pelotas 4
Piracicaba 4
Shenzhen 4
Tashkent 4
Acireale 3
Blumenau 3
Campina Grande 3
Casablanca 3
Totale 8.935
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 514
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 138
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 124
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry 112
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 97
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 87
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 86
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 82
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 82
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 79
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey 78
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 77
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 77
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 77
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry 77
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 76
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 76
Clinical implication of different plaque distribution patterns in distal left main coronary artery 75
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 75
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 74
Early cardiovascular remodelling in Fabry disease 74
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 73
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 73
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 73
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 72
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 72
Appraisal of key trials in aortic and mitral fields 72
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 72
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 72
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 72
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 72
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of Choice 71
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 71
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 70
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 70
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 70
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 69
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 69
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 69
Transfemoral transcatheter aortic-valve replacement should be preferred over surgery in most intermediate-risk patients. 69
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 68
Transcatheter Aortic-Valve Replacement 68
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 68
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 68
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 68
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 67
Update on clinical evidence (Part II): a summary of the main post market studies 67
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 66
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 66
Risk stratification after ST-elevation myocardial infarction 66
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 65
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 64
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 63
L'angioplastica complessa al posto del by-pass: ruolo degli score di rischio 63
Parenteral Anticoagulant Agents in PCI 63
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial 62
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 62
Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry 62
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry 62
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 62
Serum cotinine levels are associated with increased clopidogrel-induced antiplatelet effects 62
Capitolo 2 - Diagnostica cardiovascolare 62
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 62
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease 62
A Novel Mechanism by Which MitraClip Implantation May Favorably Alter the Natural History of Left Ventricular Remodeling in Patients with Mitral Regurgitation: Proposed Role of the Ventricular-Valvular Loop Reply 61
PHARMACODYNAMIC EFFECTS OF DIFFERENT ASPIRIN DOSING REGIMENS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE 61
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry 61
Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure. 60
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy? 60
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Results of the OPTIMUS-2 study 60
Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists 60
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 59
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 59
CABG Versus PCI In Diabetic Patients With Multivessel Disease After Risk Stratification By The SYNTAX Score: A Pooled Analysis Of The SYNTAX And FREEDOM Trials 59
Simultaneous plaque rupture and erosion in the same atheroma: insights from two and three-dimensional optical coherence tomography 58
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 58
Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation 58
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry 57
Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry 57
Drug-Eluting Stent for Left Main Coronary Artery Disease: The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment 57
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 57
Impact of Chronic Kidney Disease on Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Insights From the GRASP Registry 57
Self-apposing STENTYS stent in acute myocardial infarction 57
Impact of Residual Platelet Reactivity on reperfusion in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention 57
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonist. A review on its mechanism of action and clinical development 56
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. 56
Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients 56
Increasing CHADS2 scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleeding 56
Is isolated disease of the ostium left anterior descending or circumflex artery a distal left main pathology? 56
Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesions 55
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy 55
Impact of Adjunctive Cilostazol Therapy Versus High Maintenance Dose of Clopidogrel in Suboptimal Responders With Diabetes Mellitus 55
Clinical development of selective anticoagulants: a state of the art 54
Infarto STEMI sottoposto a riperfusione con angioplastica primaria 54
Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACS 54
Motivations for and barriers to choosing an interventional cardiology career path: Results from the EAPCI Women Committee worldwide survey 54
MitraClip Implantation for the Treatment of New-Onset Systolic Anterior Motion of the Mitral Valve After Transcatheter Aortic Valve Replacement 54
How true delivery profile diminution reduces vascular access challenges and complications 53
Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE registry) 53
SES vs PES in patients with long lesions undergoing PCI: results from a 24 months follow up 53
Totale 7.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.186 6 74 167 5 306 27 167 4 88 2 182 158
2021/20221.485 170 232 2 24 257 15 224 55 116 1 20 369
2022/20232.439 220 51 19 192 333 438 7 381 680 10 75 33
2023/20241.210 63 216 60 87 51 268 31 51 3 29 200 151
2024/20254.154 32 587 282 173 1.044 412 62 147 382 436 252 345
2025/202613 13 0 0 0 0 0 0 0 0 0 0 0
Totale 12.721